Chemokines such as CCL2, CCL5, and CXCL10 play a crucial role in the early stages of atherosclerosis via EBD as well as via atherogenic phenotype switching of VSMCs [48,49,50]. This evidence concerns the gene CCL2 and atherosclerosis.